We are live on ! Find out more
VRNA

Verona Pharma

Delisted

VRNA was delisted on the 6th of October, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$37.2M – – –
NMC
2
NEA Management Company
Maryland
$33.4M – – –
RCM
3
RA Capital Management
Massachusetts
$33.4M – – –
Wellington Management Group
4
Wellington Management Group
Massachusetts
$25.6M +$788K +113,699 +3%
VC
5
Vivo Capital
California
$19.9M – – –
PA
6
Perceptive Advisors
New York
$18.9M – – –
A
7
Abingworth
United Kingdom
$16M – – –
ACM
8
Aisling Capital Management
New York
$8.71M – – –
FCMI
9
Foresite Capital Management III
California
$7.27M – – –
SB
10
Samsara BioCapital
California
$7.27M – – –
GTC
11
Ghost Tree Capital
New York
$6.54M +$423K +60,957 +6%
PCH
12
Polar Capital Holdings
United Kingdom
$5.89M -$693K -100,000 -10%
SFM
13
Sphera Funds Management
Israel
$5.24M – – –
NHAS
14
Novo Holdings A/S
Denmark
$4.98M -$535K -77,155 -9%
TCM
15
Tekla Capital Management
Massachusetts
$4.92M – – –
BlackRock
16
BlackRock
New York
$1.64M +$1.73M +249,941 New
VP
17
venBio Partners
California
$1.06M – – –
FFM
18
Fairmount Funds Management
Pennsylvania
$549K – – –
SSA
19
Schonfeld Strategic Advisors
New York
$381K +$11.8K +1,700 +3%
DADC
20
D.A. Davidson & Co
Montana
$274K – – –
IWM
21
IHT Wealth Management
Illinois
$121K -$901 -130 -0.7%
WS
22
Wedbush Securities
California
$118K -$27.5K -3,965 -18%
FA
23
Forefront Analytics
Pennsylvania
$104K +$9.73K +1,404 +10%
HSBC Holdings
24
HSBC Holdings
United Kingdom
$101K – – –
QSS
25
Quantitative Systematic Strategies
Florida
$92K -$105K -15,136 -52%